# Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

> **NCT01470612** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 944 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** CP-690,550
- **DRUG:** CP-690,550

## Key facts

- **NCT ID:** NCT01470612
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-01
- **Primary completion:** 2020-08-06
- **Final completion:** 2020-08-06
- **Target enrollment:** 944 (ACTUAL)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01470612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01470612, "Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01470612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*